CBY1 and chronic myelogenous leukemia, BCR-ABL1 positive: To confirm that SUMOylation is a component of CBY1 down-modulation in CML, we compared signal intensities of CBY1 IP products from MCF of CML patients and HD probed with anti-SUMO antibody.